Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2005 May 21;330(7501):1208; author reply 1208-9.
doi: 10.1136/bmj.330.7501.1208.

Secondary prevention of heart disease with statins: groups were as different as chalk and cheese

James Penston
Comment

Secondary prevention of heart disease with statins: groups were as different as chalk and cheese

James Penston. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Wei L, Ebrahim S, Bartlett C, Davey PD, Sullivan FM, MacDonald TM. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials. BMJ 2005;330: 821. (9 April.) - PMC - PubMed
    1. Shepherd J, Blauw GJ, Murphy MB, Bollen ELE, Buckley BM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360: 1623-30. - PubMed
    1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the antihypertensive and lipid-lowering treatment to prevent heart attacks trial (ALLHAT-LLT). JAMA 2002;288: 2998-3007. - PubMed
    1. Sever PS, Dahlof P, Poulter NR, Wedel H, Beevers G, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo Scandinavian cardiac outcomes trial—lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361: 1149-58. - PubMed
    1. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil AW, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364: 685-96. - PubMed

MeSH terms

Substances